It is well known that systemic corticosteroids arrest the progress of vitiligo and lead to
repigmentation, but they may produce unacceptable side‐effects. The use of high‐dose …

In the recent decades, prostaglandins were recommended as a new therapeutic modality of
stable vitiligo with promising efficacy. Therefore, we designed the current work to compare …

Background Although there are several treatment options available for patients with
generalized vitiligo, their efficacy is still a matter of debate. Although shown to be effective …

Vitiligo is a common, idiopathic, acquired, depigmenting disease characterized by loss of
normal melanin pigments in the skin. The most interesting treatment methods for extensive …

Objective: To assess the effect and safety of NB-UVB for vitiligo using an evidence-based
approach. Methods: Randomized controlled trials (RCTs) on the treatment of vitiligo with NB …

Re‐pigmentation and stabilization are the two ultimate goals of any re‐pigmenting plan
designed for vitiligo management. Furthermore, whether the improvement of some vitiligo …

Background Vitiligo is a chronic cutaneous disease characterized with hypopigmented
patches that leave psychological impact on the patients. There is increasing need for new …

Vitiligo can be treated using various new and experimental therapies, such as narrow-band
ultraviolet B microphototherapy (NB-UVB), narrow-band ultraviolet B excimer laser and …

Background: Narrowband ultraviolet B (NB‐UVB) therapy has emerged as one of the most
favored treatment options in patients with generalized vitiligo. The aim of combining topical …

Background: Despite continued progress towards elucidation of the biochemical, genetic
and immunopathological pathways in vitiligo, a definitive cure remains elusive. The initial …